Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/065691external-prioritypatent/WO2013075035A1/en
Application filed by Alnylam Pharmaceuticals IncfiledCriticalAlnylam Pharmaceuticals Inc
Publication of TN2014000211A1publicationCriticalpatent/TN2014000211A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present invention provides RNAi agents, e.g., double stranded RNAi agents, that target the transthyretin (TTR) gene and methods of using such RNAi agents for treating or preventing TTR- associated diseases.
TNP2014000211A2012-08-062014-05-14Rnai agents, compositions and methods of use thereof for treating transthyretin (ttr) associated diseases
TN2014000211A1
(en)